Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Retractable Technologies, Inc. RVP

Healthcare  —  Medical Instruments & Supplies
0.70 0.02 2.94% as of 25 Sep
Market cap
$20.5M
P/E
0.0×
Insider Buys (last 12m)
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Retractable Technologies, Inc. (RVP) Business Profile

Updated before January 2025

Company Overview

Retractable Technologies, Inc. (RVP) is a medical device company headquartered in Little Elm, Texas, USA. Founded in 1994 by Thomas J. Shaw, the company was established with the mission of enhancing safety in the healthcare industry by reducing the risk of needlestick injuries and cross-contamination. Shaw, who serves as the company’s CEO and President, has been instrumental in driving innovation and growth within the organization. RVP is publicly traded on the NYSE American under the ticker symbol “RVP.”

The company is best known for its patented retractable needle technology, which has revolutionized the safety syringe market. Over the years, RVP has expanded its product portfolio and established itself as a leader in the development and manufacturing of safety medical devices. The company’s commitment to innovation, quality, and safety has earned it a strong reputation in the healthcare industry.

Core Business Segments

Safety Syringes

RVP’s flagship product line is its safety syringes, which feature a unique retractable needle mechanism. This technology minimizes the risk of needlestick injuries and contamination by automatically retracting the needle into the syringe barrel after use. Key products in this category include:

  • VanishPoint® Syringes: Known for their ease of use and reliability, these syringes are widely used in hospitals, clinics, and other healthcare settings.
  • VanishPoint® Blood Collection Devices: Designed to enhance safety during blood draws, these devices incorporate the same retractable technology.

IV Catheters

RVP also offers safety IV catheters that utilize retractable needle technology to protect healthcare workers and patients. These products are designed to reduce the risk of accidental needlestick injuries during intravenous procedures.

Other Medical Devices

In addition to syringes and IV catheters, RVP manufactures other safety medical devices, including:

  • VanishPoint® Blood Collection Tube Holders: These holders are designed to work seamlessly with the company’s blood collection devices.
  • Accessories and Custom Solutions: RVP provides a range of accessories and custom solutions to meet the specific needs of healthcare providers.

Business Model

RVP operates on a business model that integrates product innovation, manufacturing, and distribution. The company generates revenue primarily through the sale of its safety medical devices to hospitals, clinics, government agencies, and distributors. Key aspects of its business model include:

  • Patented Technology: RVP’s proprietary retractable needle technology is a cornerstone of its business, providing a competitive edge in the safety medical device market.
  • In-House Manufacturing: The company maintains strict quality control by manufacturing its products in-house at its state-of-the-art facility in Texas.
  • Global Distribution: RVP has a robust distribution network that enables it to serve customers worldwide. The company partners with distributors and government agencies to ensure its products reach healthcare providers efficiently.
  • Focus on Safety and Compliance: RVP adheres to stringent safety and regulatory standards, ensuring its products meet the highest quality requirements.

Strategic Direction

RVP is focused on expanding its product portfolio and market presence to drive future growth. Key strategic initiatives include:

  • Product Innovation: The company is investing in research and development to create new safety medical devices and improve existing products.
  • Market Expansion: RVP aims to increase its presence in international markets, particularly in regions with high demand for safety medical devices.
  • Sustainability Goals: The company is committed to reducing its environmental footprint by adopting sustainable manufacturing practices and materials.
  • Partnerships and Collaborations: RVP is exploring partnerships with healthcare organizations and government agencies to expand its reach and impact.

Competitive Landscape

RVP operates in a highly competitive market, facing competition from both established players and emerging companies. Key competitors include:

  • Becton, Dickinson and Company (BD): A global leader in medical technology, BD offers a wide range of safety syringes and other medical devices.
  • Smiths Medical: Known for its safety IV catheters and other medical products, Smiths Medical is a significant competitor in the safety device market.
  • Terumo Corporation: This Japanese company specializes in medical devices, including safety syringes and blood collection systems.
  • Cardinal Health: A major distributor of medical products, Cardinal Health also manufactures safety medical devices.

Despite the competition, RVP’s patented retractable needle technology and focus on safety give it a unique position in the market.

Risk Factors

RVP faces several risks that could impact its business operations and financial performance. Key risk factors include:

  • Market Dependence: The company relies heavily on the sale of safety syringes and other medical devices. Any decline in demand for these products could adversely affect revenue.
  • Supply Chain Disruptions: RVP’s operations could be impacted by disruptions in the supply of raw materials or components.
  • Regulatory Challenges: Compliance with stringent regulatory requirements in different markets can be complex and costly.
  • Competition: Intense competition from larger, well-established companies poses a significant challenge.
  • Economic and Geopolitical Factors: Global economic conditions and geopolitical events, such as pandemics or trade restrictions, could affect RVP’s business.

Recent Developments

RVP has made significant strides in recent years, including:

  • New Product Launches: The company has introduced advanced versions of its VanishPoint® syringes and blood collection devices.
  • COVID-19 Response: During the COVID-19 pandemic, RVP ramped up production to meet the increased demand for safety syringes used in vaccination campaigns.
  • Sustainability Initiatives: RVP has implemented measures to reduce waste and improve energy efficiency at its manufacturing facility.
  • Strategic Partnerships: The company has entered into agreements with government agencies and healthcare organizations to expand its market reach.

Investment Considerations

Strengths

  • Innovative Technology: RVP’s patented retractable needle technology sets it apart from competitors.
  • Strong Market Position: The company is a recognized leader in the safety medical device market.
  • Growth Potential: RVP’s focus on product innovation and market expansion positions it for future growth.
  • Commitment to Safety: The company’s products address critical safety concerns in the healthcare industry.

Risks

  • Market Dependence: Heavy reliance on a limited product portfolio could pose risks.
  • Regulatory Challenges: Compliance with complex regulations can be costly and time-consuming.
  • Competition: Larger competitors with greater resources could impact RVP’s market share.

Conclusion

Retractable Technologies, Inc. is a pioneering company in the safety medical device industry, known for its innovative retractable needle technology. With a strong commitment to safety, quality, and sustainability, RVP is well-positioned to capitalize on growing demand for safety medical devices. While the company faces challenges such as competition and regulatory compliance, its focus on innovation and market expansion provides a solid foundation for future growth. Investors should weigh the company’s strengths and risks carefully when considering it as a potential investment opportunity.